DXC Technology Reports Strong Q3 Free Cash Flow, Significant Capital Returns, and Raised FY26 EPS Outlook
DXC sits 18% above its 52-week low of $11.82.
Summary
DXC Technology announced Q3 FY26 results, featuring a 4.3% organic revenue decline but strong free cash flow of $266 million, $65 million in share repurchases, and $300 million in debt redemption. The company also raised its full-year non-GAAP diluted EPS guidance.
Key Events · Earnings and Guidance · DXC
-
Q3 FY26 Financial Performance
Reported total revenue of $3.19 billion, down 1.0% year-over-year (4.3% organic decline). Non-GAAP diluted EPS was $0.96, up 4.3% year-over-year, with an adjusted EBIT margin of 8.2%.
-
Strong Free Cash Flow Generation
Generated $266 million in free cash flow for the quarter, contributing to a year-to-date total of $603 million, up 4.7% year-over-year.
-
Significant Capital Allocation
Repurchased $65 million of shares and redeemed $300 million of senior notes, demonstrating a strong commitment to returning capital to shareholders and strengthening the balance sheet.
-
Updated Full-Year FY26 Guidance
Raised the midpoint of non-GAAP diluted EPS guidance to ~$3.15 (from a prior range of $2.85-$3.35) and maintained a strong free cash flow outlook of ~$650 million, despite a slight adjustment to the organic revenue decline forecast to ~4.3%.
Analysis · DXC · Technology
DXC Technology reported mixed third-quarter fiscal 2026 results, with organic revenue continuing to decline, but demonstrated strong operational execution through robust free cash flow generation and significant capital allocation. The company repurchased $65 million in shares and redeemed $300 million of senior notes, signaling a commitment to shareholder returns and balance sheet health. While organic revenue growth remains a challenge, the improved full-year EPS guidance and strong free cash flow outlook provide a more positive financial trajectory. The strategic focus on 'Fast Track solutions' and AI integration aims to reposition the company for future revenue performance.
At the time of this filing, DXC was trading at $14.00 on NYSE in the Technology sector, with a market capitalization of approximately $2.5B. The 52-week trading range was $11.82 to $23.75. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.